Data for increased Rho kinase activity in type 2 diabetic patients

被引：0
|
作者：
Liu, Lei [1 ]
Tan, Lun [1 ]
Lai, Jinsheng [1 ]
Li, Sheng [1 ]
Wang, Dao Wen [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan, Hubei, Peoples R China
来源：
DATA IN BRIEF | 2016年 / 9卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.dib.2016.11.032
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The data presented in this article are related to the research article entitled "Enhanced Rho-Kinase Activity: Pathophysiological Relevance in Type 2 Diabetes" [1]. Rho-Kinase has attracted a great deal of interest as a novel therapeutic target in cardiovascular diseases. These data describe the observed relationship of Rho-Kinase activity with type 2 diabetic patients. Rho-Kinase activity is determined by immunoblotting of peripheral blood leukocytes with the Phospho-Thr853 in the myosin-binding subunit of myosin light-chain phosphatase. The level of IL-6 is measured using Enzyme-linked immunosorbent assay. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/40).
引用
收藏
页码：978 / 982
页数：5
相关论文
共 50 条
  • [41] Platelet entropy is increased in familial hypercholesterolemia and in type 2 diabetic patients
    Bianciardi, G.
    Stefanutti, C.
    Tanganelli, I.
    INTERNATIONAL ANGIOLOGY, 2015, 34 (05) : 489 - 494
  • [42] Increased levels of ischemia modified albumin in type 2 diabetic patients
    Hermo, R
    Menini, T
    Hathuc, C
    Makins, K
    Gugliucci, A
    Kimura, S
    DIABETES, 2005, 54 : A537 - A537
  • [43] Perturbations of blood pressure homeostasis in obese/type 2 diabetic db/db mice and the involvement of rho kinase
    Su, Wen
    Yen, Chia-Hung
    Guo, Zhenheng
    Randall, David
    Brown, David
    Gong, Ming C.
    DIABETES, 2007, 56 : A192 - A192
  • [44] INHIBITION OF RHO KINASE REDUCES BLOOD PRESSURE IN HYPERTENSIVE TYPE 2 DIABETIC GOTO-KAKIZAKI RATS
    Lin, G.
    Soliman, H.
    MacLeod, K. M.
    HYPERTENSION, 2009, 54 (05) : 1179 - 1179
  • [45] Rho kinase inhibition in diabetic kidney disease
    Komers, Radko
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (04) : 551 - 559
  • [46] Physical activity in non-diabetic relatives of type 2 diabetic patients
    Bennett, SMA
    Ghunaim, SA
    Stewart, MW
    Walker, M
    DIABETOLOGIA, 1999, 42 : A113 - A113
  • [47] Rho Kinase is Increased in Tumor Surrounding Liver Tissue with Hepatocellular Carcinoma Patients
    Kumai, Toshio
    Takeba, Yuko
    Watanabe, Minoru
    Nakano, Hiroshi
    Okuse, Chiaki
    Ohthubo, Takehito
    Itoh, Fumio
    Kobayashi, Shinichi
    TUMOR BIOLOGY, 2008, 29 : 64 - 64
  • [48] Increased urinary TGF-β1 in type 2 diabetic patients with diabetic nephropathy (DN)
    Bertoluci, M
    Schaan, B
    Coimbra, T
    Schmid, H
    DIABETES, 1998, 47 : A129 - A129
  • [49] RhoA/Rho-kinase activity is increased in rat cavernosal tissue as compared to aorta
    Chitaley, K
    Mills, TM
    Webb, RC
    FASEB JOURNAL, 2001, 15 (04): : A456 - A456
  • [50] Inhibition of Rho kinase activity leads to increased osteoblast differentiation and bone formation in vitro
    Harmey, D
    Stenbeck, G
    Lax, AJ
    Grigoriadis, AE
    BONE, 2002, 30 (03) : 5S - 5S
12345